novo nordisk semaglutide mash seeks approval for for the treatment of CDSCO Clears Wegovy for MASH
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Live Spec
CDSCO Clears Wegovy for MASH India's First GLP 1 Approval for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on FDA Approves Obesity Drug Wegovy as Treatment for MASH Liver Disease DongA Science Novo Nordisk's Wegovy Gains SEC Approval for MASH Treatment in India, ETPharma Novo Nordisk will file semaglutide for MASH next year pharmaphorum Semaglutide as a MASH Treatment: What You Need to Know
Store: selfdriverentaluganda.com · Domain: selfdriverentaluganda.com


























